Fig. 7: AXNA2 partially relies on TTK to promote ESCC development. | Cell Death & Disease

Fig. 7: AXNA2 partially relies on TTK to promote ESCC development.

From: Annexin A2 combined with TTK accelerates esophageal cancer progression via the Akt/mTOR signaling pathway

Fig. 7: AXNA2 partially relies on TTK to promote ESCC development.The alternative text for this image may have been generated using AI.

A Protein changes in different treatment groups were detected by Western blot. B–D The colony formation and CCK8 assay were used to detect the rescue effect of TTK overexpression on ANXA2 deficiency. (E, F) Wound healing and transwell assay explored the migration and invasion ability of ESCC in different treatment groups. *, **, and ***, represent P < 0.05, P < 0.01, and P < 0.001, respectively.

Back to article page